Concepedia

Michelle Makiya

MM

Statistics

Publications

22

Citations

1.3K

H-Index

18

Active since

2009

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

National Institutes of Health

National Institutes of Health Clinical Center

Northwestern University

Cincinnati Children's Hospital Medical Center

Michelle Makiya is an author at National Institute of Allergy and Infectious Diseases specializing in immunology, life sciences, and immunopathology.

ORCID

Publications per year

2009–2022

22

Publications

22

The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan

Jonathan J. Kotzin, Sean P. Spencer, Sam J. McCright et al. · Nature · 2016 · 292 citations · Full text

, , +13

Benralizumab for <i>PDGFRA</i> -Negative Hypereosinophilic Syndrome

Fei Li Kuang, Fanny Legrand, Michelle Makiya et al. · New England Journal of Medicine · 2019 · 215 citations · Full text

, , +10

The eosinophil surface receptor epidermal growth factor–like module containing mucin-like hormone receptor 1 (EMR1): A novel therapeutic target for eosinophilic disorders

Fanny Legrand, Nenad Tomašević, Olga Šimáková et al. · Journal of Allergy and Clinical Immunology · 2014 · 68 citations · Full text

, , +16

Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes

Sandhya R. Panch, Michael Bozik, Thomas Brown et al. · Blood · 2018 · 63 citations · Full text

, , +6

Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease

Fei Li Kuang, Michelly Sampaio De Melo, Michelle Makiya et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 63 citations · Full text

, , +14

1–5 of 22